Serum IL-17 levels are higher in critically ill patients with AKI and associated with worse outcomes

BACKGROUND: Interleukin-17 (IL-17) antagonism in rats reduces the severity and progression of AKI. IL-17-producing circulating T helper-17 (TH17) cells is increased in critically ill patients with AKI indicating that this pathway is also activated in humans. We aim to compare serum IL-17A levels in...

Descripción completa

Detalles Bibliográficos
Autores principales: Collett, Jason A., Ortiz-Soriano, Victor, Li, Xilong, Flannery, Alexander H., Toto, Robert D., Moe, Orson W., Basile, David P., Neyra, Javier A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008961/
https://www.ncbi.nlm.nih.gov/pubmed/35422004
http://dx.doi.org/10.1186/s13054-022-03976-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008961/
https://www.ncbi.nlm.nih.gov/pubmed/35422004
http://dx.doi.org/10.1186/s13054-022-03976-4

Ejemplares similares